Clinical Trial Update: EPO906 Therapy in Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for EPO906 therapy in advanced breast cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• EPO906

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED